Upcoming Webinar
Advancing Operational Excellence: Optimizing ESR1 Testing in Oncology Care
Date: April 16, 2025 | 2:00 PM
Login to Watch this Webinar
To watch the live webinar, login to your account or register to gain access to our exclusive content.
Join us for an in-depth exploration of endocrine therapy resistance in HR+, HER2- advanced breast cancer, with a focus on ESR1 mutations and their impact on treatment decisions.
This session will cover essential insights to guide clinical practice:
-
Types of endocrine therapy resistance and the role of ESR1 mutations
-
Testing guidelines and clinical implementation of ESR1 mutation testing
-
Available therapies targeting ESR1 mutations and best practices for patient care
Speakers:
Julia Lea Ziegengeist, PharmD, BCOP | Atrium Health
Heather N. Moore, PharmD, BCOP, CPP | Duke University Hospital
If you have any questions or would like to request the meeting invite, contact Jonathan Rivera.